Navigation Links
Drug Fails to Slow Progression of Atherosclerosis
Date:3/17/2009

Pactimibe also was associated with more risk of major heart problems, study finds

TUESDAY, March 17 (HealthDay News) -- A drug that blocks an enzyme involved in the accumulation of cholesterol does not reduce the progression of atherosclerosis, thickening and stiffening of the arteries, but increases the risk of major cardiovascular events, according to an international study.

Researchers assessed the safety and efficacy of the drug pactimibe, which inhibits an enzyme known as ACAT, in 892 people with a family history of high cholesterol, which is associated with an increased risk of atherosclerosis. The participants, from 40 clinics in the United States, Canada, Europe, South Africa and Israel, were randomly selected to take either 100 milligrams a day of pactimibe or a placebo, in addition to standard lipid-lowering therapy.

The researchers assessed the participants' atherosclerosis at the start of the study and 12, 18 and 24 months later using ultrasound to measure carotid intima-media thickness (CIMT), a measurement of the thickness of the inner wall of a major artery. Increasing thickness indicates increasing plaque in the artery.

After six months, levels of "bad" low-density lipoprotein (LDL) cholesterol had increased by 7.3 percent among people taking pactimibe and by 1.4 percent among those taking the placebo. This increase disappeared after participants stopped taking the drug.

There was no difference between the two groups in progression of maximum CIMT, but average CIMT progressed significantly in the pactimibe group within one year, compared with minor CIMT progression in the placebo group, the study found.

Compared with people in the placebo group, those in the pactimibe group suffered more serious events (10 percent vs. 7.7 percent) and more cardiovascular events (6.3 percent vs. 3.4 percent) and had a higher rate for the composite of cardiovascular death, heart attack and stroke
'/>"/>

Copyright©2009 ScoutNews,LLC.
All rights reserved  

Page: 1 2

Related medicine news :

1. Federal research plan to determine nanotech risks fails to deliver
2. States HMO Report Card Fails in Meaningful Evaluation of Health Care Quality and Ignores Affordability
3. Emergency Care for Heart Attacks, Pneumonia Fails to Meet Goals
4. Experimental Drug Fails Against Heart Failure
5. NSAID Drug Therapy Fails to Ease Back Pain
6. MedPAC Again Fails to Evaluate Overall Economic Conditions in Assessing SNF Funding Requirements
7. Steroid Fails to Ease Meningitis in Trials
8. Pharmaceutical market fails pregnant women; and more
9. Progress toward an alternative for EPO: Gas6 offers remedy where EPO fails today
10. Post-Op Chemo Fails to Boost Survival in Stomach Cancers
11. Broad Stakeholder Coalition Concludes that the Pathway for Biosimilars Act Fails to Ensure Timely Access to Safe, Affordable Biogeneric Medicines for Patients
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Drug Fails to Slow Progression of Atherosclerosis
(Date:8/21/2014)... 2014 The new program, WellnessConnect ... Companies and builds on Accountable Health Solutions’ DiabetesConnect? ... combined with Accountable Health’s robust member engagement capabilities, ... and adds a custom incentive platform to help ... provider visits, HbA1c testing and more. ...
(Date:8/21/2014)... Sleep Apnea Doctors US is now offering complimentary ... with a convenient way to find new patients in their ... closer to finding remedies for sleep apnea . Many ... this sleep disorder , thus the majority of sleep ... to Sleep Apnea Doctors U.S., finding sleep doctors and receiving ...
(Date:8/21/2014)... Cary, NC (PRWEB) August 21, 2014 ... solutions for the health and human services markets, announced ... features and capabilities incorporating the Tin Can API. ... and their employees have the most advanced mobile learning ... greatest in adult learning tools and techniques,” says Jim ...
(Date:8/21/2014)... (PRWEB) August 21, 2014 ... high-quality patient safety and efficacy endpoint data ... 2014 Regional Conference Series: Maximizing Product Value ... 1-day educational events enable biopharmaceutical developers to ... in interactive discussions on developing, implementing, and ...
(Date:8/21/2014)... be elicited by T-type calcium channels in the ... influxes of calcium. These channels enable thalamic reticular ... neurons to enter a hyper-excited state. , In ... and absence seizures, the researchers conducted an experiment ... targeting techniques to delete the T-type calcium channel ...
Breaking Medicine News(10 mins):Health News:Accountable Health Expands Diabetes Management Solutions to Address Gaps in Provider Care 2Health News:Accountable Health Expands Diabetes Management Solutions to Address Gaps in Provider Care 3Health News:Sleep Apnea Doctors US is Now Offering Complimentary Listings to Sleep Apnea Doctors Across the United States 2Health News:Relias Learning Announces Support for Tin Can API 2Health News:ERT Opens Registration for PROFICIENCY™ Regional Conference Series 2Health News:ERT Opens Registration for PROFICIENCY™ Regional Conference Series 3
... months , , TUESDAY, Feb. 10 (HealthDay News) -- Flu ... humidity levels are low, such as in the peak ... , A link between humidity and flu prevalence and ... been on relative humidity, not absolute humidity, according to ...
... 10 Zeus, Inc. is pleased to introduce ... live and accessible via http://www.zeusinc.com .With innovative ... user-friendly resource for comprehensive information about Zeus products ... conveniently organizes an extensive amount of information into ...
... SAN DIEGO, Feb. 10 Mpex Pharmaceuticals, Inc. ... million initial closing of a Series D financing ... include RiverVest Venture Partners, as well as existing ... and Adams Street Partners. These investors have made ...
... industry,s first ever patient-positioning pads developed specifically for ... by Sechrist Industries, the world leader in hyperbaric ... Pads(TM) are available in three multifunctional configurations -- ... give maximum versatility and flexibility in achieving optimum ...
... Feb. 10 Four western New York hospitals,using ... among health care providers reduced heart attack patient,deaths ... after patient discharge. , ... Strategies: Improved Treatment and Reduced Mortality in Patients,with ...
... Inc., a developer of innovative therapies in women,s health, ... health insurers with over 17 million members, is now ... (SUI) in non-pregnant women who are either not able ... According to Aetna,s updated policy posted on its website, ...
Cached Medicine News:Health News:Low Humidity Levels Help Flu Germs Spread 2Health News:Mpex Pharmaceuticals Announces Series D Financing of Up to $40 Million 2Health News:Mpex Pharmaceuticals Announces Series D Financing of Up to $40 Million 3Health News:Mpex Pharmaceuticals Announces Series D Financing of Up to $40 Million 4Health News:Sechrist Introduces Hyperbaric Industry's First Patient-Positioning Pads Designed for Use in Hyperbaric Chambers 2Health News:Sechrist Introduces Hyperbaric Industry's First Patient-Positioning Pads Designed for Use in Hyperbaric Chambers 3Health News:Emergency Treatment Strategies, Better Communication Among Health Care Workers Reduce Heart Attack Patient Deaths by 19 Percent, Says AHJ Published Study 2Health News:Emergency Treatment Strategies, Better Communication Among Health Care Workers Reduce Heart Attack Patient Deaths by 19 Percent, Says AHJ Published Study 3Health News:Emergency Treatment Strategies, Better Communication Among Health Care Workers Reduce Heart Attack Patient Deaths by 19 Percent, Says AHJ Published Study 4Health News:Aetna Now Covers Novasys Medical's Renessa(R) Treatment for Incontinence in Women 2
(Date:8/21/2014)... Schein, Inc. (NASDAQ: HSIC ), the world,s largest ... animal health and medical practitioners, announced today that the Company ... , September 4, 2014 – Baird 2014 Healthcare Conference in ... , September 8, 2014 – Morgan Stanley ... NY at 1:25 p.m. ET Henry Schein,s presentations ...
(Date:8/21/2014)... 2014  The board of directors of VirtualScopics, Inc. ... clinical trial imaging solutions, today announced that James ... effective immediately.  Mr. Groff has held the role of ... VirtualScopics in January 2006 as an accounting manager and ... "When the board of VirtualScopics asked Jim to assume ...
(Date:8/21/2014)...  SI-BONE, Inc. ( San Jose, California ... of the iFuse Implant System, ® a minimally ... sacroiliac (SI) joint, announced that Priority Health ( ... Fusion Medical Policy No. 91590-R4 providing positive coverage for ... that the fusion procedure, which employs the iFuse Implant ...
Breaking Medicine Technology:Henry Schein To Present At Two Investor Conferences In September 2VirtualScopics, Inc. Names James Groff Chief Financial Officer 2VirtualScopics, Inc. Names James Groff Chief Financial Officer 3VirtualScopics, Inc. Names James Groff Chief Financial Officer 4SI-BONE, Inc. Announces Positive Coverage Decision by Priority Health 2SI-BONE, Inc. Announces Positive Coverage Decision by Priority Health 3
... New Mexico Software, Inc. (OTC ... IT services and solutions that enable improved and faster communication ... providing second opinion teleradiology interpretation for its customers. ... for patients and their families who want a second opinion ...
... 2011 Fujitsu , the market ... showcase its network scanning solutions for improved information sharing ... the Annual HIMSS Conference & Exhibition (Booth #5750) in ... network scanners has gained tremendous momentum by helping healthcare ...
Cached Medicine Technology:New Mexico Software Initiates Medical Second Opinion Service via Telemedicine for Remote Consultation Review 2New Mexico Software Initiates Medical Second Opinion Service via Telemedicine for Remote Consultation Review 3Fujitsu to Showcase New Document Imaging Technologies for Improved Information Sharing and Record Keeping at HIMSS 2011 2Fujitsu to Showcase New Document Imaging Technologies for Improved Information Sharing and Record Keeping at HIMSS 2011 3
... The total ergonomic solution and best ... Soft, feather touch action and ultra lightweight ... Stress-free tip ejection with long, lever tip ... identification , Accepts universal tips or for ...
... The Finnpipette BioControl multichannel ... features as the single ... handle fits allseven multichannel ... tip cone modules. Both ...
... Pipette is ideal for all liquid handling ... ergonomically-placed operating buttons, and various dispensing techniques ... diluting make this a lab favorite. It ... manual pipette without any adverse effects on ...
... Design for Unparalleled Comfort Pick one of ... balance. Notice the trigger and ejector positionsright where ... our pipettors are ergonomically designed to help avoid ... pipetting. Productivity In The Palm Of Your ...
Medicine Products: